Thursday - April 30, 2026
Alzheimer's Association Welcomes FDA Approval of First Non-Antipsychotic Treatment for Alzheimer's Disease Agitation
April 30, 2026
CHICAGO, Illinois, April 30 [Category: Health Care] -- The Alzheimer's Association posted the following news release:

* * *

Alzheimer's Association Welcomes FDA Approval of First Non-Antipsychotic Treatment for Alzheimer's Disease Agitation

*

CHICAGO, April 30, 2026 -The Alzheimer's Association welcomes today's U.S. Food and Drug Administration (FDA) approval of Auvelity(r) (AXS-05, dextromethorphan-bupropion, Axsome Th . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products